Together, these findings indicate that inhibition of Drp1 suppresses autophagy activation, which further blocks BMPR2 lysosomal degradation and Id1 downregulation, thus to prevent MCT‐induced PAH development. Here, BMPR2 is linked to pulmonary arterial hypertension.